'the trial continues to progress well and on time with retention of all participants who have been enrolled - the trial team have identified no safety concerns to date '
very nice update
- Forums
- ASX - By Stock
- IHL
- Ann: Independent data review commences for Ph 2 trial psilocybin
Ann: Independent data review commences for Ph 2 trial psilocybin, page-5
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)